Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook




 

Gene discovered that regulates the immune response to infection

03 December 2012

By Daryl Ramai

Appeared in BioNews 684

Scientists have discovered a gene that controls the immune response against infection. The finding may help in the development of treatments for some chronic infections.

The study in mice showed that the gene Arih2 was critical to the survival of embryos. In mice with a deficiency in Arih2 that did survive beyond birth, the decrease in Arih2 enhanced their immune responses to lethal effect. The mice experienced a temporary boost in their immune systems, but eventually died as their immune systems began attacking their own cells.

Lead author Dr Marc Pellegrini at the Walter and Eliza Hall Institute of Medical Research says: 'Arih2 is responsible for the most fundamental and important decision that the immune system has to make - whether the immune response should be initiated and progressed or whether it should be switched off to avoid the development of chronic inflammation or autoimmunity'.

Dr Pellegrini notes that in chronic conditions, diseases can overwhelm our immune systems. 'During evolution, some organisms have evolved ways of exhausting our immune system to the point where the immune system just switches off, and this is what happens in HIV, hepatitis B and tuberculosis'.

The researchers hope that by controlling the activity of Arih2, these chronic infections could be successfully cleared. Co-author Dr Greg Ebert, also at the Walter and Eliza Hall Institute of Medical Research, says: 'Because Arih2 is critical for survival, we now need to look at the effect of switching off the gene for short periods of time, to see if there is a window of opportunity for promoting the immune response to clear the infection without unwanted or collateral damage or autoimmunity'.

Future work will focus on creating a drug that can temporarily 'switch off' Arih2. Developing such a drug for human use will take many years, however Dr Pellegrini is hopeful, stating that: 'It [Arih2] is probably one of the few genes and pathways that is very targetable and could lead to a drug very quickly'.

The study was published in Nature Immunology.

SOURCES & REFERENCES
Nature Immunology | 25 November 2012
 
Reuters UK | 26 November 2012
 
Mail Online | 27 November 2012
 
Walter and Eliza Hall Institute of Medical Research (press release) | 26 November 2012
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

05 May 2015 - by Dr James Heather 
US researchers have used the CRISPR/Cas9 system to target hepatitis C infection in human cells...
19 January 2015 - by Kirsty Oswald 
A twin study has shown that the majority of variation in immunity between individuals is due to non-genetic factors.
08 April 2013 - by Matthew Thomas 
For the first time, scientists have observed how the human immune system makes antibodies capable of neutralising the human immunodeficiency virus (HIV), confirming the belief that their production occurs only after the virus has started to diversify....
04 February 2013 - by Dr Charlotte Warren-Gash 
The bacteria that cause tuberculosis (TB) evade immune cells and drug treatments by hiding in bone marrow stem cells, according to research...

19 November 2012 - by Helen Brooks 
A single genetic mutation increases the risk of developing Alzheimer’s disease by threefold, say scientists from two independent research groups...
30 April 2012 - by Dr Victoria Burchell 
A gene identified in MRSA may contribute to the spread and virulence of the superbug. The gene - sasX - is located in a segment of DNA called a mobile genetic element and is capable of jumping from one bacterium to another...
05 March 2012 - by Ayesha Jadoon 
Early trials in patients with chronic granulomatous disorder (x-CGD), a recessive X-linked condition that affects the immune system, have shown signs of success following the use of gene therapy. The observed boost in immunity of those undergoing treatment was only temporary, however, and the faulty gene causing x-CGD was not corrected permanently....
20 February 2012 - by Oliver Timmis 
What time of day it is could influence whether or not we get an infection. A protein known to be involved in the immune system may be influenced by the body's circadian rhythm, according to researchers at Yale University...
05 December 2011 - by Dr Tamara Hirsch 
US scientists have induced long-lasting HIV protection in mice from a single injection. Their study, published in the journal Nature, uses gene therapy to stimulate production of antibodies against the virus...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation